CIP
CDLX icon

CAS Investment Partners’s Cardlytics CDLX Stock Holding History

CAS Investment Partners’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.11M Sell
470,986
-48,821
-9% -$365K 0.11% 6
2026
Q1 		$5.46M Hold
519,807
– – 0.31% 4
2025
Q4 		$5.98M Hold
519,807
– – 0.26% 5
2025
Q3 		$12.6M Sell
519,807
-41,585
-7% -$693K 0.56% 4
2025
Q2 		$9.23M Hold
561,392
– – 0.45% 4
2025
Q1 		$10.2M Sell
561,392
-75,499
-12% -$2.16M 0.66% 4
2024
Q4 		$23.6M Sell
636,891
-5,082
-0.8% -$194K 1.38% 4
2024
Q3 		$20.5M Sell
641,973
-4,513
-0.7% -$250K 1.36% 4
2024
Q2 		$53.1M Buy
646,486
+9,118
+1% +$986K 4.15% 4
2024
Q1 		$92.4M Buy
637,368
+95,756
+18% +$8.09M 8.28% 4
2023
Q4 		$49.9M Hold
541,612
– – 6.03% 5
2023
Q3 		$89.4M Hold
541,612
– – 11.46% 4
2023
Q2 		$34.2M Hold
541,612
– – 5.21% 5
2023
Q1 		$18.4M Hold
541,612
– – 3.77% 5
2022
Q4 		$31.3M Hold
541,612
– – 7.48% 4
2022
Q3 		$50.9M Hold
541,612
– – 9.29% 4
2022
Q2 		$121M Hold
541,612
– – 18.32% 3
2022
Q1 		$298M Buy
541,612
+22,965
+4% +$13.9M 19.93% 3
2021
Q4 		$343M Buy
518,647
+3,688
+0.7% +$2.82M 17.89% 3
2021
Q3 		$432M Buy
514,959
+66,062
+15% +$67M 20.6% 2
2021
Q2 		$570M Hold
448,897
– – 24.24% 2
2021
Q1 		$492M Hold
448,897
– – 25.16% 2
2020
Q4 		$641M Buy
448,897
+9,738
+2% +$10.4M 35.51% 2
2020
Q3 		$310M Buy
439,159
+37,734
+9% +$27.4M 21.48% 2
2020
Q2 		$281M Buy
401,425
+6,273
+2% +$3.62M 30.25% 2
2020
Q1 		$138M Buy
395,152
+112,981
+40% +$80M 30.38% 2
2019
Q4 		$177M Buy
282,171
+50,230
+22% +$24.6M 29.17% 2
2019
Q3 		$77.7M Buy
231,941
+15,739
+7% +$5.05M 17.17% 3
2019
Q2 		$56.2M Buy
+216,202
New +$43.3M 14.39% 3

Other funds holding CDLX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $122M AUM 11.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

CAS Investment Partners's CDLX Position: Q2 2026 in Review

CAS Investment Partners reduced its Cardlytics (CDLX) stake by 9.4% in Q2 2026, selling an estimated $365K and leaving 470,986 shares worth $2.11M. The position accounts for 0.11% of the portfolio, ranked #6.

CAS Investment Partners first reported a position in CDLX in Q2 2019 and has held it in 29 quarters since. The position peaked at $641M in Q4 2020. 42 funds tracked by Wall St. Rank hold CDLX as of Q2 2026.

  • CAS Investment Partners held 470,986 shares of Cardlytics worth $2.11M as of Q2 2026.
  • CAS Investment Partners sold 48,821 Cardlytics shares in Q2 2026, an estimated $365K.
  • Cardlytics made up 0.11% of CAS Investment Partners's portfolio in Q2 2026, its #6 holding.
  • CAS Investment Partners first reported a position in Cardlytics in Q2 2019 and has held it in 29 quarters since.
  • CAS Investment Partners's Cardlytics position peaked at $641M in Q4 2020.
  • 42 funds tracked by Wall St. Rank held Cardlytics as of Q2 2026.

Based on CAS Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.